In-Person Access Only | 7.50 CE/CME Credits & MOC Points
All programs remain free. Registrations will require a credit card as a cancellation hold. A fee of $99 will only be incurred in the event of a no-show or cancellation within 5 days without written confirmation to the Total Health Program Team.
The 11th Annual West Oncology Conference serves as a valuable forum for presenting and discussing new research findings in oncology education.
Learners are provided updates on practice-changing data in breast cancers, genitourinary cancers, hematological malignancies, gastrointestinal cancers, and lung cancers – all in a practical and interactive format, fostering discussion and impacting patient clinical outcomes. This accredited meeting is an in-person conference with on-demand access for registered attendees.
Conference Agenda Saturday, January 31, 2026
8:00 AM
Coffee and Exhibits
8:30 AM
Program Chair Welcome
8:40 AM
Updates in Colorectal Cancer
9:00 AM
Updates in Non-Colorectal Cancer
Tyler Johnson, MD | Stanford University
9:20 AM
Panel Discussion and Q&A - Gastrointestinal Cancer
Axel Grothey, MD (Moderator) | West Cancer Center
Tyler Johnson, MD | Stanford University
Noam Vanderwalde, MD, MS | West Cancer Center
9:50 AM
Updates in Small Cell Lung Cancer
Melissa Johnson, MD | Sarah Cannon Research Institute
10:10 AM
Updates in Non Small Cell Lung Cancer
Balazs Halmos, MD, MS | Montefiore Einstein
10:30 AM
Panel Discussion and Q&A - Lung Cancer
Ramakrishna Battini, MD (Moderator) | West Cancer Center
Jason Porter, MD | West Cancer Center
Melissa Johnson, MD | Sarah Cannon Research Institute
Balazs Halmos, MD, MS | Montefiore Einstein
Harvey Poret, MD | St. Francis Hospital
Yuefeng Wang, MD, PhD | West Cancer Center
11:00 AM
Breakfast and Exhibits
11:15 AM
Non-CME Breakfast Taiho - LONSURF + bevacizumab for the Treatment of 3L Metastatic Colorectal Cancer
Saurin Chokshi, MD | The University of Tennessee Health Science Center
12:00 PM
MRD as an Endpoint in Multiple Myeloma
Susan Bal, MD | The University of Alabama at Birmingham
12:20 PM
AML and Molecular Targets with MRD Testing
Alice Mims, MD | The Ohio State University
12:40 PM
Preparing a Patient for CAR-T - Guidance to Community Oncologists
Bryan Huber, MD | Intermountain Health
1:00 PM
Panel Discussion and Q&A - Hematological Malignancies
Jason Chandler, MD (Moderator) | West Cancer Center
Susan Bal, MD | The University of Alabama at Birmingham
Alice Mims, MD | The Ohio State University
Bryan Huber, MD | Intermountain Health
1:30 PM
Lunch and Exhibits
1:45 PM
Non-CME Lunch
2:30 PM
Housekeeping and Survey
2:40 PM
Latest Update in MRD
3:00 PM
Solid Tumor Molecular Board Panel
Axel Grothey, MD (Moderator) | West Cancer Center
Amber Fifield, PhD | Caris Life Sciences
Emily Mason, MMSc, CGC | Guardant Health - Medical Affairs
Minetta Liu, MD | Natera
t
3:30 PM
Liquid Tumor Molecular Board Panel
Jason Chandler, MD (Moderator) | West Cancer Center
Mihaela Onciu, MD | West Cancer Center
Susan Bal, MD | The University of Alabama at Birmingham
Alice Mims, MD | The Ohio State University
Bryan Huber, MD | Intermountain Health
4:00 PM
Networking Reception
5:00 PM
Adjourn
Sunday, February 1, 2026
8:00 AM
Coffee and Exhibits
8:30 AM
Program Chair Welcome
8:40 AM
Updates in Non-Prostate Cancer
Ben Garmezy, MD | Sarah Cannon Research Institute
9:00 AM
Updates in Prostate Cancer
Manojkumar Bupathi, MD | Rocky Mountain Cancer Centers
9:20 AM
Panel Discussion and Q&A - Genitourinary Cancer
Brad Somer, MD (Moderator) | West Cancer Center
Ben Garmazy, MD | Sarah Cannon Research Institute
Manojkumar Bupathi, MD | Rocky Mountain Cancer Centers
Holger Gieschen, MD | West Cancer Center
Nikhil Gopal, MD | University of Tennessee Health Science Center
9:50 AM
Breakfast and Exhibits
10:05 AM
Non-CME Breakfast
10:50 AM
Where is AI going in Oncology?
Christopher Merlan | Chief Digital Officer (CDO) at American Society of Clinical Oncology (ASCO)
11:25 AM
Threats and Opportunities of IRA and MFN in Oncology
11:55 AM
Transitioning to Outpatient Bite Therapy
Stephen Divers, MD | Genesis Cancer and Blood Institute
12:25 PM
Lunch and Exhibits
12:40 PM
Non-CME Lunch
1:25 PM
Management of HER2 Low and HER2 Ultra Low
Erica Stringer-Reasor, MD | UAB O’Neal Comprehensive Cancer Center
1:40 PM
Management HER2+
Erin Cobain, MD | University of Michigan Medical School
2:05 PM
Panel Discussion and Q&A - Breast Cancer
Gregory Vidal, MD, PhD | West Cancer Center
Alyssa Pittman, MD (Moderator) | West Cancer Center
Erica Stringer-Reasor, MD | UAB O’Neal Comprehensive Cancer Center
Erin Cobain, MD | University of Michigan Medical School
Noam Vanderwalde, MD, MS | West Cancer Center
Richard Gilmore, MD | West Cancer Center
2:35 PM
Adjourn
Agenda Subject To Change. All times are CST.
-
Identify novel targeted and immunologic approaches to therapy for various cancers
Integrate recent findings on healthcare disparities into optimal therapy selection for individual patients with cancer
Identify optimal therapies for patients and managing and mitigating side effects
Describe findings from recent clinical trials evaluating immunotherapies
Identify strategies to prevent and manage the treatment related adverse events of targeted therapies and immunotherapies to improve tolerability and maintain quality of life
Foster discussions on equitable and equal access and delivery of care for disparate populations, including discussing research and drug and diagnostic pipeline development that include underserved and underrepresented patients
-
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nurses (ANCC) Credit Designation
Amedco LLC designates this activity for a maximum of 7.50 ANCC contact hours.Physicians (ACCME) Credit Designation
Amedco LLC designates this live activity for a maximum of 7.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Pharmacists and Pharmacy Technicians (ACPE) Credit Designation
Amedco LLC designates this activity for a maximum of 7.50 knowledge-based CPE contact hours.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of your participation in the activity to meet the deadline for submission to CPE Monitor.
American Board of Internal Medicine (ABIM) MOC Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.50 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. You must request your certificate within 30 days of the activity to meet the deadline for submission to PARS.
-
Free registration for all healthcare providers
Expert sessions that present the most clinically relevant data, research, and clinical strategies
Enduring video content for watching at your leisure
Real-time discussion and debate
Networking with peers, colleagues, and medical professionals
Access to the latest industry information and resources
Catered meals through-out the program